【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hyperphenylalaninemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hyperphenylalaninemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hyperphenylalaninemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hyperphenylalaninemia 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Hyperphenylalaninemia Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Teijin Limited 32
Clinical Trial Overview of Teijin Limited 32
Takeda Pharmaceutical Company Limited 33
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 33
Sanofi 34
Clinical Trial Overview of Sanofi 34
AstraZeneca PLC 35
Clinical Trial Overview of AstraZeneca PLC 35
Fuji Yakuhin Co., Ltd. 36
Clinical Trial Overview of Fuji Yakuhin Co., Ltd. 36
BioMarin Pharmaceutical Inc. 37
Clinical Trial Overview of BioMarin Pharmaceutical Inc. 37
Sanwa Kagaku Kenkyusho Co., Ltd. 38
Clinical Trial Overview of Sanwa Kagaku Kenkyusho Co., Ltd. 38
Nuon Therapeutics, Inc. 39
Clinical Trial Overview of Nuon Therapeutics, Inc. 39
Japan Tobacco Inc. 40
Clinical Trial Overview of Japan Tobacco Inc. 40
BioCryst Pharmaceuticals, Inc. 41
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
Kyushu University 42
Clinical Trial Overview of Kyushu University 42
University of Otago 43
Clinical Trial Overview of University of Otago 43
China Medical University Hospital 44
Clinical Trial Overview of China Medical University Hospital 44
National Cerebral and Cardiovascular Center 45
Clinical Trial Overview of National Cerebral and Cardiovascular Center 45
Tottori University Hospital 46
Clinical Trial Overview of Tottori University Hospital 46
Fukushima Medical University 47
Clinical Trial Overview of Fukushima Medical University 47
The University of Texas Health Science Center at Houston 48
Clinical Trial Overview of The University of Texas Health Science Center at Houston 48
The Medical Center Leeuwarden 49
Clinical Trial Overview of The Medical Center Leeuwarden 49
Juntendo University School of Medicine 50
Clinical Trial Overview of Juntendo University School of Medicine 50
Midorigaoka Hospital 51
Clinical Trial Overview of Midorigaoka Hospital 51
Five Key Clinical Profiles 52
Appendix 93
Abbreviations 93
Definitions 93
Research Methodology 94
Secondary Research 94
About GlobalData 95
Contact Us 95
Disclaimer 95
Source 95
【レポート販売概要】
■ タイトル：高フェニルアラニン血（Hyperphenylalaninemia）：グローバル臨床試験レビュー（2014年上半期）■ 英文：Hyperphenylalaninemia Global Clinical Trials Review, H1, 2014
■ 発行日：2014年4月30日
■ 調査会社：GlobalData
■ 商品コード：GDHC2124CTIDB
■ 調査対象地域：グローバル
- グローバル石油市場における政府の規制動向（2014年Q3）Third Quarter 2014 Regulatory Outlook Summary Report reflects key actions undertaken by Governmental Agencies impacting the current and future oil environment. These rulings / adjustments to existing regulations could impact trade flows and / or impact project timing with an impact on Capital Expenditures. Report considers changes in environmental regulations, Court rulings impacting projects, cha …
- 世界の太陽光発電市場2013Global Solar PV Market Outlook in 2013 – Consolidation and Downstream Integration by Upstream Companies Summary The solar Photovoltaic (PV) industry will attempt to stabilize in 2013. Moreover, this year will be characterized by the consolidation and downstream integration of solar PV upstream companies, which will help to decrease the excess inventory of modules in the market. Companies will work …
- 使い捨てゴミ袋の世界市場2019-2023About this market Emergence of recycled disposable garbage bags to drive growth in the market. As raw material prices have risen significantly while many are difficult to procure, disposable garbage bags manufacturer have begun using recyclable PET plastics as raw materials. Technavio’s analysts have predicted that the disposable garbage bags market will register a CAGR of almost 5% by 2023. Marke …
- スマートグリッド市場分析：Analyzing the Smart GridToday’s electric power grid is primarily composed of central generating stations and electromechanical power delivery systems operated from control centers. However, the system is transforming itself into a smart grid that integrates a multitude of distributed energy resources, uses solid state electronics to manage and deliver power, and employs automated control systems. The smart grid will achi …
- クロールアルカリ（Chlor-Alkali）製品の世界市場：塩素、苛性曹達、ソーダ灰などChlorine, caustic soda and soda ash are widely used in the global chemical, glass, plastic and various other industries. In 2013, the three products of chlor-alkali had total demand of 187,919KT globally. The Asia-pacific region is the biggest market of chlor-alkali products, accounting for more than half of the total global demand. There is a lot of scope in Asian and European market, with the bo …
- モデルマウスの世界市場分析・予測（～2021）：近交系モデルマウス、ノックアウトモデルマウス、雑種モデルマウスThe mice model market is expected to reach USD 1.59 Billion in 2021 from USD 1.11 Billion in 2016, growing at a CAGR of 7.5%. Ongoing innovations in mice models, personalized medicine driving the demand for humanized mice models, continuous support in the form of investments and grants, and growing pharmaceutical R&D activities are some of the factors that are expected to drive the growth of the g …
- 皮膚糸状菌爪真菌症（DO）：企業と競争環境PharmaPoint: Dermatophytic Onychomycosis (DO) - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Dermatophytic Onychomycosis (DO) - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing DO Market. The report identifies and analyses the key companies shaping and dr …
- ガードレールの世界市場The global crash barrier systems market is estimated to grow at a CAGR of 3.12% from 2015-2020. The growth of this market is propelled by an increase in the roadway infrastructure and automotive industry throughout the world. Crash barriers also play an important role in highway commuter safety. With the emergence of new technologies, manufacturers are looking for advanced techniques to make crash …
- 世界の農業接種剤市場2015The Global Agricultural Inoculants Industry Report 2015 is a professional and in-depth study on the current state of the Agricultural Inoculants industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Agricultural Inoculants market analysis is provided for the international markets including development tr …
- スマートファブリック及びインタラクティブ織物の世界市場About Smart Fabrics and Interactive Textiles Smart fabrics and interactive textiles are those textiles that can respond to external environmental stimuli, such as moisture, temperature change, pressure, magnetism, and other stimuli. Various textiles can be embedded with electronics, digital components or additives, like silver, to enhance the desired functionalities. The high performance and cost- …
- 排液排出ゼロ（ZLD）システムの世界市場予測（～2023年）“The zero liquid discharge systems market is projected to grow at a CAGR of 8.3% between 2018 and 2023.”The zero liquid discharge (ZLD) systems market is estimated to be USD 5.4 billion in 2018 and is projected to reach USD 8.1 billion by 2023, at a CAGR of 8.3% from 2018 to 2023. Key factors expected to drive the zero liquid discharge systems market include the implementation of stringent environ …
- 欧州主要国の末梢血管処置用機器市場見通し（～2021）EU5 Peripheral Vascular Procedures Outlook to 2021 Summary GlobalData’s new report, "EU5 Peripheral Vascular Procedures Outlook to 2021", provides key procedures data on the EU5 Peripheral Vascular Procedures. The report provides procedure volumes within market segments - Aortic Open Repair Procedures, Aortic Stent Graft Procedures, Carotid Artery Embolic Protection Procedures, Deep Seated Artery …
- 癌免疫療法の世界市場：製品別（腫瘍溶解性ウイルス療法・癌ワクチン、モノクローナル抗体、免疫調節剤）、癌種類別（乳房、肺）、セグメント予測The global cancer immunotherapy market size is likely to reach USD 126.9 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 9.6% during the forecast period. Increasing patient pool and higher mortality rate are augmenting the need for cancer immunotherapy globally. Furthermore, increasing number of approvals for new immunotherapeutic drugs is driving the …
- 世界防衛産業の持続可能性レポート2013-2014Why was the report written? This report is a result of responses derived from SDI’s exclusive B2B panel of senior decision making respondents and helps in understanding the implementation of sustainability in the industry and its impact on business. It also includes analysis of responses from senior stakeholders, including detailed segmentation, which helps the reader to make well-informed busines …
- 世界の塩素化ポリオレフィン市場2015Global Chlorinated Polyolefin Industry Report 2015 is a professional and in-depth study on the current state of the Chlorinated Polyolefin industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Chlorinated Polyolefin market analysis is provided for the international markets including development trends, …
